BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17599735)

  • 1. Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints.
    Williams AS; Richards PJ; Thomas E; Carty S; Nowell MA; Goodfellow RM; Dent CM; Williams BD; Jones SA; Topley N
    Arthritis Rheum; 2007 Jul; 56(7):2244-54. PubMed ID: 17599735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
    Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
    Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis.
    Marijnissen RJ; Roeleveld DM; Young D; Nickerson-Nutter C; Abdollahi-Roodsaz S; Garcia de Aquino S; van de Loo FA; van Spriel AB; Boots AM; van den Berg WB; Koenders MI
    Arthritis Rheumatol; 2014 Apr; 66(4):886-95. PubMed ID: 24757141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
    Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis.
    Szekanecz Z; Halloran MM; Volin MV; Woods JM; Strieter RM; Kenneth Haines G; Kunkel SL; Burdick MD; Koch AE
    Arthritis Rheum; 2000 Jun; 43(6):1266-77. PubMed ID: 10857785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis.
    Talbot J; Bianchini FJ; Nascimento DC; Oliveira RD; Souto FO; Pinto LG; Peres RS; Silva JR; Almeida SC; Louzada-Junior P; Cunha TM; Cunha FQ; Alves-Filho JC
    Arthritis Rheumatol; 2015 Jul; 67(7):1751-9. PubMed ID: 25779331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response.
    Irmler IM; Gajda M; Bräuer R
    J Immunol; 2007 Nov; 179(9):6228-36. PubMed ID: 17947698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.
    Ross AD; Banda NK; Muggli M; Arend WP
    Arthritis Rheum; 2004 Nov; 50(11):3702-11. PubMed ID: 15529385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.
    Coelho FM; Pinho V; Amaral FA; Sachs D; Costa VV; Rodrigues DH; Vieira AT; Silva TA; Souza DG; Bertini R; Teixeira AL; Teixeira MM
    Arthritis Rheum; 2008 Aug; 58(8):2329-37. PubMed ID: 18668539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.
    Mould AW; Tonks ID; Cahill MM; Pettit AR; Thomas R; Hayward NK; Kay GF
    Arthritis Rheum; 2003 Sep; 48(9):2660-9. PubMed ID: 13130487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.